PRECIGEN, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)

Item 7.01 Regulation FD Disclosure.

On January 11, 2023, Precigen, Inc. (the "Company") issued a press release providing an overview of certain research and development and corporate updates that the Company presented at the 41st Annual J.P. Morgan Healthcare Conference on January 11, 2023. A copy of the press release is attached hereto as Exhibit 99.1.

This information, including the Exhibit attached hereto, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.

  Item 9.01 Financial Statements and Exhibits.




(d) Exhibits



  Exhibit 99.1     Press Release issued by Precigen, Inc., dated January 11, 2023.

104              Cover Page Interactive Data File (embedded within the Inline XBRL
                 document).

© Edgar Online, source Glimpses